US Bancorp’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

US Bancorp’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-25	Closed	-$2K	–	3682
2016 Q4	$2K	Hold	25	–	–	﹤0.01%	3407
2016 Q3	$2K	Hold	25	–	–	﹤0.01%	3391
2016 Q2	$2K	Buy	+25	New	+$2.29K	﹤0.01%	3426
2015 Q3	–	Sell	-101	Closed	-$96K	–	3716
2015 Q2	$96K	Buy	101 +65	+181%	+$53.1K	﹤0.01%	2169
2015 Q1	$26K	Buy	+36	New	+$27K	﹤0.01%	2851

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

US Bancorp's TTPH Position: Q1 2017 in Review

US Bancorp sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2017, closing a stake of 25 shares — an estimated $2K sold.

US Bancorp first reported a position in TTPH in Q1 2015 and held it in 5 quarters. The position peaked at $96K in Q2 2015. 89 funds tracked by Wall St. Rank hold TTPH as of Q1 2017.

US Bancorp reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
US Bancorp sold 25 Tetraphase Pharmaceuticals, Inc. shares in Q1 2017, an estimated $2K.
US Bancorp first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
US Bancorp's Tetraphase Pharmaceuticals, Inc. position peaked at $96K in Q2 2015.
89 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2017.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.